Recombinant Human RPS3A Protein, N-His

Description of Recombinant Human RPS3A Protein, N-His

Introduction

Recombinant proteins have become an essential tool in various fields of biomedical research, diagnostics, and therapeutics. One such protein is Recombinant Human RPS3A Protein, which has gained significant attention due to its unique structure and diverse functions. In this article, we will discuss the structure, activity, and applications of Recombinant Human RPS3A Protein.

Structure of Recombinant Human RPS3A Protein

Recombinant Human RPS3A Protein is a 30S ribosomal protein that is encoded by the RPS3A gene. It consists of 246 amino acids with a molecular weight of approximately 28 kDa. The protein has a conserved S1 domain, which is responsible for its RNA binding activity. It also has a C-terminal domain that is involved in protein-protein interactions. Recombinant Human RPS3A Protein has been extensively studied, and its crystal structure has been determined, revealing its unique three-dimensional conformation.

Activity of Recombinant Human RPS3A Protein

Recombinant Human RPS3A Protein has multiple functions, including its role as a ribosomal protein. It is a component of the 40S ribosomal subunit, which is responsible for protein synthesis. Recombinant Human RPS3A Protein also has RNA binding activity, which is crucial for its role in translation initiation. Additionally, it has been shown to have non-ribosomal functions, such as its involvement in DNA repair and transcriptional regulation.

One of the most intriguing activities of Recombinant Human RPS3A Protein is its ability to act as an antigen. It has been identified as a target antigen in several autoimmune diseases, including systemic lupus erythematosus and rheumatoid arthritis. This has sparked interest in studying the antigenic properties of Recombinant Human RPS3A Protein and its potential role in the development of autoimmune disorders.

Applications of Recombinant Human RPS3A Protein

Due to its unique structure and diverse functions, Recombinant Human RPS3A Protein has a wide range of applications. One of its most significant uses is in the production of recombinant vaccines. Recombinant Human RPS3A Protein has been identified as a potential vaccine candidate against various bacterial and viral infections. Its ability to elicit an immune response and its role as an antigen make it a promising target for vaccine development.

Recombinant Human RPS3A Protein has also been used in diagnostics, particularly in the detection of autoimmune diseases. Its antigenic properties have made it a valuable biomarker for the diagnosis and monitoring of these diseases. Additionally, Recombinant Human RPS3A Protein has been used in research studies to understand its role in various cellular processes, including ribosome biogenesis, translation, and DNA repair.

Furthermore, Recombinant Human RPS3A Protein has potential therapeutic applications. It has been shown to have anti-inflammatory properties, and its involvement in autoimmune diseases has made it a target for drug development. Recombinant Human RPS3A Protein has also been studied for its role in cancer, as it has been found to be overexpressed in various types of cancer, including breast and lung cancer. This has opened up possibilities for using Recombinant Human RPS3A Protein as a therapeutic target in cancer treatment.

Conclusion

In conclusion, Recombinant Human RPS3A Protein is a versatile protein with a unique structure and diverse functions. Its role as a ribosomal protein, RNA binding activity, and antigenic properties make it a valuable tool in various fields of research, diagnostics, and therapeutics. With ongoing studies and advancements in recombinant protein technology, the potential applications of Recombinant